Ajanta Pharma Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and ThreatsAjanta Pharma Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats| Promoters increased pledged shares QoQ | 28.5% returns for Nifty 500 over 2.9 years |
| MFs decreased their shareholding last quarter | 190% returns for over 6.4 years |
| Inefficient use of capital to generate profits - RoCE declining in the last 2 years | -9.0% returns for Nifty 500 over 1.9 years |
| High promoter stock pledges | |
| Highest increase in pledges by promoters |
| Brokers upgraded recommendation or target price in the past three months | 8.4% returns for Nifty 500 over 0.3 years |
| High Momentum Scores (Technical Scores greater than 50) | 319.5% returns for Nifty 500 over 5.1 years |
| Negative to Positive growth in Sales and Profit with Strong Price momentum | |
| Stocks near 52 Week High with Significant Volumes |
| Expensive Stars (DVM) | 4708.8% returns for Nifty 500 over 10.2 years |
| Companies with 10% increase in share price over three months, with rising net profit growth | |
| Companies with high market cap, lower public shareholding | |
| Rising Net Cash Flow and Cash from Operating activity | 375.3% returns for Nifty 500 over 5.9 years |
| Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks | 187.6% returns for Nifty 500 over 4.5 years |
| Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks | 181.7% returns for Nifty 500 over 4.5 years |
| Stocks with Expensive Valuations according to the Trendlyne Valuation Score | 177.2% returns for Nifty 500 over 4.5 years |
| Top Losers |